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Basic cellular homeostatic processes such as gene transcription, protein synthesis, and division are dependent on the precise spatio-temporal coordination of intracellular Ca 2ϩ release into the cytoplasm and its subsequent sequestration into Ca 2ϩ storage organelles or its extrusion from the cell (1) . Defective Ca 2ϩ handling has been implicated in many pathological conditions, including cardiac abnormalities, neurodegenerative disease, polycystic kidney disease, and cancer (2) (3) (4) (5) (6) . Much attention has focused on the encryption of complex Ca 2ϩ signals underpinning homeostasis in healthy cells and how these are altered in pathogenic states to invoke cell death pathways (7, 8) . Cell survival is thought to involve the "silencing" of cell death machinery, for example, pro-apoptotic elements are refractory to Ca 2ϩ -driven signals in healthy cells, and alterations of the frequency/amplitude encryption of Ca 2ϩ signals invoke specific cell death programs (9) .
In Ca 2ϩ -driven cell death, the Ca 2ϩ storage status of the endoplasmic reticulum (ER) 1 and the levels of cytoplasmic free Ca 2ϩ ([Ca 2ϩ ] c ) are proposed as the main determinants of cell fate, but the relative contribution of these in triggering cell death pathways is widely debated. Augmented ER Ca 2ϩ load in COS cells caused cell death (10) , whereas depletion of ER Ca 2ϩ was toxic in SH-SY5Y neurons (11) . Similarly, depletion of ER Ca 2ϩ appeared to have a protective function for HeLa cells (12) , in contrast to pancreatic B-cells where increased ER Ca 2ϩ storage protected from nitric oxide-induced apoptosis (13) . Studies in hippocampal neurons showed that increased [Ca 2ϩ ] c was sufficient to mediate cell death (14) and in astrocytes similar elevation in [Ca 2ϩ ] c is achieved solely from influx of extracellular Ca 2ϩ with negligible involvement of intracellular Ca 2ϩ stores (15) . Conversely, it has been shown that a moderate and sustained elevation of cytoplasmic Ca 2ϩ in neurons is protective (16) .
Other cellular elements contribute to modulation of the intracellular Ca 2ϩ signal. The close apposition of mitochondria with the ER is implicated in shaping cellular Ca 2ϩ phenomena (17) and mitochondrial function appears crucial in both cell survival (18) and destruction (9) . The spatial organization of Ca 2ϩ release channels, ryanodine receptors (RyR), or inositol 1,4,5-trisphosphate receptors (IP 3 R) cells appears to be of key importance in determining cellular fate. Increased density of IP 3 R and RyR triggers cell death (19 -21) , and the finding that both IP 3 R and RyR can directly sense cytoplasmic and luminal Ca 2ϩ environments (22) (23) (24) suggests that Ca 2ϩ itself is a key transducer in the activation of programmed cell death.
We have investigated the specific role of RyR in mediating altered cellular phenotype. RyRs are large homotetrameric channels (molecular mass, ϳ2.3 MDa) that mediate Ca 2ϩ release from sarcoplasmic reticulum (SR) in skeletal and cardiac muscle. Recent evidence predicts that in situ RyRs do not exist as discrete entities but act as scaffolding complexes that integrate a multitude of regulatory signals from accessory proteins, including calmodulin, FK506-binding protein (FKBP), protein kinase A, and protein phosphatases (25, 26) . It has been demonstrated that altered stoichiometry between RyR and inter-acting accessory proteins results in pathogenic Ca 2ϩ signaling. For example, dissociation of the RyR2⅐FKBP12.6 complex induces an aberrant leak of Ca 2ϩ from the SR, which is implicated in the pathogenesis of heart failure (27, 28) .
We have generated CHO cells stably expressing discrete levels of recombinant human cardiac RyR (CHO hRyR2 ) and showed that a selective interaction occurred between hRyR2 and co-expressed FKBP12.6, which critically modulated the Ca 2ϩ release activity of hRyR2 in situ (29) . This study investigates the empirical observation that CHO hRyR2 exhibit increased cellular toxicity and decreased proliferation when compared with wild-type CHO cells. We demonstrate that these phenotypic changes are underscored by perturbations in cellular Ca 2ϩ handling specifically mediated by hRyR2. Normal cellular phenotype was restored by modulating hRyR2-mediated Ca 2ϩ release via co-expression of FKBP12.6, which highlighted the role of FKBP12.6 in homeostatic Ca 2ϩ signaling and cell function. Our data indicate that expression of hRyR2 in an FKBP12.6-deficient context leads to increased cytoplasmic Ca 2ϩ flux, without an accompanying change in mean cytoplasmic Ca 2ϩ levels, which is deleterious to cell survival.
EXPERIMENTAL PROCEDURES
All cell culture materials, plastic ware, and LipofectAMINE 2000 were obtained from Invitrogen (Paisley, UK). Rapamycin, thapsigargin, and ryanodine were from Calbiochem (Nottingham, UK). AlamarBlue was from BIOSOURCE International (Nivelles, Belgium). Fluo3-AM, BAPTA-AM, DiOC 6 (3), and Alexa-conjugated secondary antibodies were from Molecular Probes (Leiden, Netherlands). All other chemicals were from Sigma (Poole, UK).
Cell Culture and Analysis of Recombinant Protein Expression-Chinese hamster ovary (CHO hRyR2 ) cells stably expressing discrete levels of hRyR2 (29) were routinely cultured in supplemented nutrient Ham's F-12 medium (containing fetal calf serum (10% (v/v), amphotericin B (2.5 g/ml), and G418 sulfate (500 g/ml)). CHO WT cells were cultured in supplemented nutrient Ham's F-12 medium lacking G418 sulfate. In some experiments, cells were transfected with plasmid pCR3 (Invitrogen, UK) encoding human FKBP12 or FKBP12.6 using Lipofect-AMINE2000 in a ratio of 0.8 g:1 g (DNA:lipid) according to the manufacturer's protocol, and transfection efficiencies of Ͼ85% were routinely achieved. FKBP-hRyR2 interaction was disrupted following incubation of cells with rapamycin (5 M).
Immunoblotting analysis of recombinant hRyR2 in post-nuclear supernatants obtained from wild-type CHO (CHO WT ) and CHO hRyR2 was performed as described using an RyR2-specific antibody, pAb129 (30) . The cellular expression of endogenous and recombinant FKBP12 and FKBP12.6 isoforms was determined using a rabbit polyclonal anti-FKBP12 antibody (see below) in immunoblotting analysis of post-nuclear supernatants (100 g) obtained from CHO WT and CHO hRyR2 following separation of proteins on 20% (v/v) acrylamide SDS-PAGE (29) .
Immunofluorescent localization of endogenous IP 3 R and recombinant hRyR2 in CHO hRyR2 cells was performed using pAb-40 (anti-IP 3 R, 1:250 dilution) (31) and pAbN-19 (anti-RyR, 1:500 dilution) (Santa Cruz Biotechnology), respectively, followed by subsequent detection using donkey secondary antibodies conjugated to Alexa488 (IP 3 R) and Alexa546 (RyR) as previously described (29) . The extent of co-localization between IP 3 R and RyR signals was quantified using Scanware software (Leica). DiOC 6 (3) (0.5 M) was used to visualize the ER in RyR-deficient CHO WT cells. Production of Anti-FKBP12 Polyclonal Antiserum-Recombinant human FKBP12-glutathione S-transferase (hFKBP12-GST) fusion protein was generated as previously described (32) . hFKBP12-GST (250 g), complexed with glutathione-Sepharose beads (Amersham Biosciences) and resuspended in PBS (250 l) after extensive washing in PBS, was emulsified with an equal volume of Freund's Complete adjuvant (first immunization) or Freund's Incomplete adjuvant (second and third immunizations) prior to subcutaneous injection into adult New Zealand White female rabbits (University College Cork Biological Services Unit). Purified hFKBP12 (50 g) (Sigma) emulsified in Freund's Incomplete adjuvant as above was used as the final immunogen. Antiserum was isolated from whole blood following clotting and was stored in sodium azide (0.02% (w/v)).
Determination of Cell Death Modality and Cell Proliferation-Cell viability was determined 36 h post-seeding using Trypan blue (0.4% (w/v) in PBS (NaCl, 140 mM; KCl, 2.7 mM; Na 2 HPO 4 , 10 mM; NaH 2 PO 4 , 2 mM; pH 7.4) and propidium iodide (PI; 1 g/ml in PBS) permeability assays (33) . The plasma membranes of viable cells are impermeable to Trypan blue and PI, and only cells that were stained positively by both Trypan blue and PI were confirmed to be non-viable. Cells were visualized using phase (Trypan blue) and fluorescent microscopy (PI; Em max Ͼ 620 nm), respectively. All assays were performed on adherent cells, and there was negligible detachment of cells from the culture surface throughout these experiments as determined by hemocytometric measurement of aspirated culture medium (data not shown).
The extent of apoptotic cell death was quantified using a fluorometric TdT-mediated dUTP nick-end labeling (TUNEL) assay (DeadEnd TM , Promega, UK). Briefly, resting cells or cells preincubated with modulators of intracellular Ca 2ϩ handling (see below) were fixed in paraformaldehyde (3% (v/v) in PBS), permeabilized in Triton X-100 (0.2% (v/v) in PBS), and incubated in buffer containing terminal deoxynucleotidyl transferase enzyme (25 units) for 1 h at 37°C to incorporate fluorescein-12-dUTP into caspase-fragmented DNA, a phenotypic marker of apoptosis. Cells were washed in 2ϫ SSC (300 mM NaCl, 30 mM sodium citrate; pH 7.0), and apoptotic cells were identified by the presence of highly fluorescent nuclei (Em max , 511 nm).
Determination of Cellular Proliferation-The proliferative capacity of sub-confluent CHO WT and CHO hRyR2 cells was determined on the same cell populations at 24-h intervals for 96 h. Cells were incubated with medium containing AlamarBlue (10% (v/v)) for 5 h prior to fluorometric analysis of aspirated medium (LS50B, PerkinElmer Life Sciences). Cellular metabolic activity reduces AlamarBlue from a nonfluorescent (blue) form into a fluorescent (red) form (Ex max , 560 nm; Em max , 590 nm). The oxidized and reduced forms of AlamarBlue are freely cell permeable and do not contribute to cellular toxicity (34) . The seeding density of cells was adjusted to ensure that the cells were sub-confluent throughout these procedures. The data obtained using AlamarBlue cell viability assays was corroborated by hemocytometric measurement of cell number performed in parallel experiments. ] c was calculated from fluorescent data using: (36) . F max and F min were determined following the addition of ionomycin (1 M) and EGTA (5 mM), respectively, at the end of experiments. Cells grown on coverslips were loaded with fluo3-AM (15 M) for 1 h at 23°C in Krebs-Ringer-Hepes medium (KRH; 120 mM NaCl, 25 mM Hepes, 4.8 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgCl 2 , 5.5 mM glucose, 1.3 mM CaCl 2 ; pH 7.4), and immediately prior to experiments, cells were transferred to KRH containing nominal free Ca 2ϩ (KRH-Ca 2ϩ , where EGTA (1 mM) replaced CaCl 2 ). Resting and agonist-stimulated [Ca 2ϩ ] c was measured in cells using a confocal microscope (SP2, Leica, Heidelberg, Germany) in bidirectional scan mode (512-ϫ 64-pixel resolution) controlled with Leica software.
Measurement of [Ca
To specifically trigger Ca 2ϩ release through hRyR2, 4-chloro-m-cresol (4-CMC; 0.5 mM) was added to cells, and Ca 2ϩ release through endogenously expressed IP 3 R (37) was triggered by the intracellular generation of IP 3 from PIP 2 via the activation of purinergic (P2Y) receptors using ATP (1 mM) (38) . To investigate the effects of blocking RyR-mediated Ca 2ϩ release, cells were exposed to ryanodine (1 mM) for 15 h or for 2 h prior to agonist-stimulated Ca 2ϩ release. IP 3 R-mediated Ca 2ϩ release was inhibited by cytoplasmic loading of heparin using a hypo-osmotic pinocytic lysis procedure (39) . Briefly, cells were incubated in Leibowitz L-15 medium containing sucrose (0.5 M), polyethylene glycol 1000 (10%, v/v), and heparin (5 mg/ml) for 5 min to form heparin-containing pinocytic vesicles. Cells were exposed to hypo-osmotic media (6 parts L-15 medium to 4 parts water) for 2 min to promote pinocytic lysis and the distribution of heparin throughout the cytoplasm, prior to rinsing and further culturing in normal nutrient F-12 media. This procedure, which resulted in the loading of ϳ95% cells as determined by cytoplasmic localization of fluorescent fluorescein isothiocyanate-dextran, did not contribute to cell toxicity (data not shown). In some experiments, cells were loaded with BAPTA-AM (0. , when compared with CHO WT , was estimated following calculation of the F ratio (40 (Fig. 1A) . The normal morphology of CHO WT cells is shown with typically 2-4% of cells exhibiting altered morphology (Fig. 1B, panel a,  arrowed ). In contrast, CHO H , a cell line stably expressing high levels of hRyR2, were characterized by a dramatically increased prevalence of small, morphologically altered cells (Fig.  1B, panel b, arrowed) , a small proportion of which exhibited significant cell surface membrane blebbing (Fig. 1B, panel c) , a phenotypic marker of apoptotic cell death. CHO L cells, which express lower levels of hRyR2 (Fig. 1A) , also exhibited pronounced cellular toxicity (Fig. 1B, panel d, arrowed) with evidence of apoptosis (Fig. 1B, panel e) . We determined a marked reduction in the viability of resting CHO hRyR2 when compared with CHO WT , which was proportional to the expression levels of hRyR2, i.e. viability of CHO H Ͻ CHO L Ͻ Ͻ CHO WT (Fig. 1C,  panel b) . The normal modulation of RyR2 requires a multitude of accessory proteins, some of which are not endogenously expressed in CHO cells (21, 29) and thus our CHO hRyR2 cell model provides a powerful platform to determine the impact of defective hRyR2 Ca 2ϩ signaling on cell function. Inhibition of hRyR2 Ca 2ϩ release by incubation of cells with ryanodine (1 mM) fully restored the viability of CHO hRyR2 cells to levels measured in CHO WT (Fig. 1C, panel b) , indicating that the increased cell death measured in CHO hRyR2 was mediated by the expression of functional hRyR2. Analysis of the mode of cell death in resting CHO hRyR2 identified significantly elevated levels of necrotic cell death, which was prevented following ryanodine-mediated inhibition of hRyR2 (Fig. 1C, panel a) . These data are in broad agreement with findings that heterologous expression of RyR produces marked phenotypic changes when compared with wild-type host cell lines (21, 41, 42) , but our results extend these findings by demonstrating that cell death in resting (non-stimulated) cells expressing functional hRyR2 predominantly occurs via necrosis. However, the precise mechanistic basis of necrosis is unknown in these cells, and thus throughout this study the term "necrosis" refers to a currently undefined mechanism of cell death that is distinct from apoptosis.
Increased (Fig.  2B, panel a) , we observed that increased expression of hRyR2 was associated with a concordant increase in "noise" (flux) in resting Ca 2ϩ signals recorded in CHO hRyR2 cells ( Fig. 2A, " control" traces). We hypothesized that the increased amplitude of Ca 2ϩ flux measured in CHO hRyR2 , which is clearly apparent in Fig. 2A (Fig. 2B, panel a) (Fig. 2B, panel b) . hRyR2 Interaction with FKBP12. 6 Prevents Cell Deathcells, we co-expressed FKBP12.6, a potent modulator of RyR2 function (27, 29) and determined its effects on Ca 2ϩ handling and cellular phenotype in CHO hRyR2 cells. Polyclonal antiserum raised against FKBP12, a homologue of FKBP12.6 that does not functionally interact with RyR2 (29, 43, 44) , crossreacted with FKBP12.6 owing to a high degree of sequence homology (85%) (Fig. 2C) . FKBP12 exhibits an extensive tissue distribution (43) and was endogenously expressed in CHO WT and CHO hRyR2 cells. In contrast, FKBP12.6 is expressed at far lower levels in tissues (45) and was not detected in post-nuclear fractions obtained from these cells (Fig. 2C, left panel) . High level expression of recombinant FKBP12.6 in CHO hRyR2 cells (Fig. 2C, middle panel) was associated with significantly decreased intracellular Ca 2ϩ flux (Fig. 2, A and B, panel b) and a concordant restoration of CHO hRyR2 viability (Fig. 2D ). In contrast, co-expression of FKBP12 (Fig. 2C, right panel) had little effect on the magnitude of cytoplasmic Ca 2ϩ flux (Fig. 2, A and  B, panel b) and did not affect cell viability (Fig. 2C ) consistent with the absence of FKBP12-hRyR2 interaction. However, in complete agreement with ryanodine inhibition of hRyR2 (Fig.  1 ), FKBP12.6 expression was associated with a reduced necrosis in the few non-viable cells (ϳ5% of the total population), which persisted (Fig. 2D, panel a) . Disruption of specific protein-protein interaction between FKBP12.6-hRyR2 using rapamycin (46) 
hRyR2 Interaction with FKBP12.6 Prevents Cell Death
hRyR2-mediated cytoplasmic Ca 2ϩ flux (Fig. 2, A and B, panel  b) and abolished the pro-survival effects of FKBP12.6 in CHO hRyR2 (Fig. 2D) . Interestingly, the restoration of cell viability following co-expression of FKBP12.6 in CHO hRyR2 was associated with a marked potentiation of the ER Ca 2ϩ store (Fig. 2B, panel c) suggesting that super-filling ER Ca 2ϩ stores did not directly contribute to CHO hRyR2 cell death. However, there was close correlation between the magnitude of cytoplasmic Ca 2ϩ flux and the extent of cell toxicity (R 2 ϭ 0.937), strongly indicating that increased cytoplasmic Ca 2ϩ flux, independent of resting [Ca 2ϩ ] c or ER Ca 2ϩ load status, is a key determinant of CHO hRyR2 cell viability. Furthermore, the finding that FKBP12.6 expression had a marked pro-survival effect on CHO hRyR2 by inhibiting the increased cytoplasmic Ca 2ϩ flux through hRyR2 may go some way to providing a mechanistic basis for the use of FKBP12.6-mediated strategies as a candidate therapy in preventing the abnormal SR Ca 2ϩ efflux underpinning heart failure (47). Although it is widely accepted and clearly demonstrated in the present work that hRyR2 Ca 2ϩ release is modulated by interaction with FKBP12.6, controversy exists as to the precise nature of RyR2-FKBP12 interaction (48, 49) . In the present context of our CHO hRyR2 cell system, we show that FKBP12 does not interact functionally with hRyR2.
We next investigated the effect of biochemical modulation of hRyR2-mediated cytoplasmic Ca 2ϩ flux on cell phenotype. In agreement with the data obtained following co-expression of FKBP12.6 in CHO hRyR2 cells, ryanodine-mediated inhibition of recombinant hRyR2 did not affect [Ca 2ϩ ] c (Fig. 3B, panel a) , yet significantly reduced cytoplasmic Ca 2ϩ flux (Fig. 3, A and B, panel b) and restored cellular viability (Fig. 3C, panel b) by prevention of necrotic cell death (Fig. 3C, panel a) . This prosurvival effect of ryanodine in CHO hRyR2 was associated with augmentation of the ER Ca 2ϩ capacity (Fig. 3B, panel c) . We used BAPTA to directly investigate the phenotypic effects of suppressing cytoplasmic Ca 2ϩ flux in CHO hRyR2 and CHO WT cells. However, because normal cell processes are dependent on coordinated fluctuations in [Ca 2ϩ ] c , BAPTA treatment (Ͼ0.5 M) was associated with a dose-dependent toxicity (data not shown), and thus lower concentrations were used (0.1 M), because this adequately suppressed cytoplasmic Ca 2ϩ fluctuations (Fig. 3A) yet did not adversely affect the cell viability during these experiments. Incubation of cells with BAPTA-AM (0.1 M, 15 h), a potent inhibitor of apoptosis (50) (Fig. 3C,  panel a) , decreased resting [Ca 2ϩ ] c and ER Ca 2ϩ load (Fig. 3B,  panels a and c, respectively) , markedly suppressed intracellular Ca 2ϩ flux (Fig. 3, A and B, panel b) and restored CHO hRyR2 cell viability (Fig. 3C, panel b) . Inhibition of endogenously expressed IP 3 R following cytoplasmic loading of heparin had little effect on resting [Ca 2ϩ ] c , cytoplasmic Ca 2ϩ flux, and ER Ca 2ϩ load (Fig. 3B, panels a-c, respectively) , and accordingly, CHO hRyR2 viability remained low (Fig. 3C) . Taken together, our findings do not predict a clear role for mean resting [Ca 2ϩ ] c or altered ER Ca 2ϩ load in the decreased cell viability of CHO hRyR2 but strongly indicate that CHO hRyR2 toxicity is underscored by increased hRyR2-mediated cytoplasmic Ca 2ϩ flux. Cells are tolerant of moderate cytoplasmic Ca 2ϩ fluxes, which encrypt homeostatic signaling events (7, 8) , and the dramatic loss of cell viability in CHO hRyR2 highlights the extent to which expression of dysregulated hRyR2 perturbs the normal mode of Ca 2ϩ signaling. 3 R-Our results point to a pivotal role of increased hRyR2 Ca 2ϩ release in initiating necrotic cell death in resting CHO hRyR2 , and hence we investigated the phenotype resulting from activation of hRyR2 in agonist-stimulated cells. Addition of 4-CMC (0.5 mM), a potent and specific activator of hRyR2 Ca 2ϩ release (51), increased [Ca 2ϩ ] c in CHO hRyR2 , and the magnitude of Ca 2ϩ release was proportional to the levels of hRyR2 expressed in each cell type (CHO H Ͼ CHO L ) (Fig. 4A) . No Ca 2ϩ was released in CHO
Apoptosis Is Triggered following Agonist Activation of hRyR2 or via Functional Interaction with Endogenous IP
WT following addition of 4-CMC (Fig. 4A) , confirming hRyR2 Interaction with FKBP12.6 Prevents Cell Deaththat CHO WT does not express functional levels of RyR, and CHO WT cell viability remained high (Fig. 4C) . Ryanodine treatment abolished 4-CMC-induced Ca 2ϩ release in CHO hRyR2 populations, whereas inhibition of endogenous IP 3 R using heparin had no effect on Ca 2ϩ release triggered by 4-CMC (Fig. 4A ). This moderate increase in [Ca 2ϩ ] c upon 4-CMC addition to CHO H and CHO L cells (0.32 Ϯ 0.04 and 0.17 Ϯ 0.03 M, respectively) was associated with a profound decrease in cellular viability via apoptosis (Fig. 4B) . Ryanodine inhibition of hRyR2 prevented apoptosis, whereas heparin had no effect on 4-CMC-induced cellular toxicity (Fig. 4B, gray bars) highlighting a role for hRyR2 Ca 2ϩ release in determining the extent and mode of cell death in CHO hRyR2 . The initiation of apoptotic pathways following the activation of skeletal muscle RyR (RyR1) in heterologous expression systems has been reported (21), but our data highlight a fundamental switch in cell death mechanisms upon agonist-induced Ca 2ϩ mobilization. Although apoptosis and necrosis are proposed to share common initiating programs (50, 52) (Fig. 2B, panel c) . Importantly, in CHO WT cells maintained in nominal free extracellular Ca 2ϩ , ATP addition did not decrease cell viability, whereas a similar magnitude of Ca 2ϩ release in CHO hRyR2 produced significant cell death via apoptosis, the extent of which was proportional to the expression levels of hRyR2 (Fig. 4D) . Cytoplasmic loading of heparin abolished IP 3 R-dependent Ca 2ϩ release in all cells (Fig. 4C ) and prevented cell death in CHO hRyR2 (Fig. 4D) indicating that the ATP-induced toxicity in CHO hRyR2 cells required the activation of endogenous IP 3 R. Importantly, following incubation of CHO hRyR2 cells with ryanodine, the magnitude of ATP-induced Ca 2ϩ release was decreased (Fig. 4C ) and resulted in a remarkable preservation of cell viability (Fig. 4D) . These results raise the intriguing possibility that the pronounced loss of viability in CHO hRyR2 following IP 3 R-activation is specifically mediated by Ca 2ϩ release from ryanodine-sensitive stores via hRyR2. In accord with this hypothesis, this loss did not occur in RyR-deficient CHO WT cells where viability remained intact following 4-CMC or ATP addition (Fig. 4, A-D) . There was extensive intracellular co-localization between recombinant hRyR2 and endogenous IP 3 R in CHO H and CHO L cells (90 Ϯ 7% and 94 Ϯ 5% coincidence (yellow), respectively (n ϭ 6)) with both Ca 2ϩ release channels displaying a perinuclear latticelike distribution characteristic of the ER network (Fig. 5) . It has been shown that spatially coincident IP 3 R and RyR Ca 2ϩ release channels participate in functional "cross-talk" (53, 54) , and indeed, our results suggest that activation of IP 3 R (heparin-sensitive) triggered Ca 2ϩ release via recombinant hRyR2 (ryanodine-sensitive), which critically modulated the CHO hRyR2 phenotype. These data also provided compelling evidence that the loss of cell viability in agonist-stimulated CHO hRyR2 was underpinned by the mode of Ca 2ϩ release (i.e. via hRyR2) rather than the magnitude of Ca 2ϩ release. We currently do not know the precise mechanism by which activation of IP 3 R triggers hRyR2 Ca 2ϩ release in these cells, or conversely, how activation of recombinant hRyR2 fails to trigger Ca 2ϩ release via IP 3 R, but it is likely that cellular machinery required to permit functional interaction between these Ca 2ϩ release channels (25, 53, 54) are present in CHO hRyR2 . Clearly, a more refined analysis of sub-cellular Ca 2ϩ mobilization is required to more fully elucidate the molecular basis of this phenomenon.
We demonstrated a profound effect of FKBP12.6, but not FKBP12, in restoring the viability of resting CHO hRyR2 cells via hRyR2 Interaction with FKBP12.6 Prevents Cell Deaththe specific modulation of hRyR2 Ca 2ϩ release (Fig. 2) , and thus we investigated whether the beneficial effects of FKBP12.6 persisted in agonist-stimulated CHO hRyR2 cells. In CHO WT , co-expression of FKBP12.6 did not affect Ca 2ϩ release triggered by 4-CMC or ATP (Fig. 6, A and C, respectively) , confirming that FKBP12.6 did not functionally interact with endogenous IP 3 R and had no impact on viability or mode of cell death (Fig. 6B, panels b and a, respectively) . In contrast, FKBP12.6 inhibited 4-CMC or ATP-triggered Ca 2ϩ release in CHO hRyR2 cells (Fig. 6 , A and C, respectively) and preserved CHO hRyR2 cell viability by inhibiting apoptosis (Fig. 6, B and  D) . Rapamycin antagonized the beneficial effects of FKBP12.6 on intracellular Ca 2ϩ release (Fig. 6 , A and C) and CHO hRyR2 viability (Fig. 6, B and D (Fig. 7A) . However, although cells did not reach confluency during the experiment, the rate of proliferation slowed as the cell density increased (days 1-4) (Fig. 7A, panels a-d) , suggesting that the proliferation of CHO WT and CHO hRyR2 was sensitive to the ambient cellular environment. Modulation of hRyR2 by ryanodine (Fig.  7A, panel b ) and FKBP12.6 (Fig. 7A, panel d) restored CHO hRyR2 cellular proliferation rates to those measured in CHO WT cells (Fig. 7B ). Expression of FKBP12 had no effect on the cell growth (Fig. 7A, panel c) . Incubation of cells with heparin or BAPTA (even at 0.1 M) for the duration of the experiments resulted in total cell death (data not shown), presumably due to the sustained inhibition of normal homeostatic signaling events, which are dependent on endogenous IP 3 R Ca 2ϩ release (1). These results indicate that biochemical (ryanodine) or physiological (FKBP12.6) modulation of hRyR2, which inhibits pathological fluxes in cytoplasmic Ca 2ϩ (Figs.  2-3 ), restored normal cell proliferation in populations of CHO hRyR2 . Thus, an important demonstration in the present study is that the co-expression of recombinant FKBP12.6 was necessary and sufficient to regulate RyR2, whereas FKBP12 did not interact with RyR2 and had no discernible effect on cellular phenotype in our model.
Although we cannot exclude the possibility that the decreased proliferation of CHO hRyR2 reflected decreased ATP availability due to the energy demands of continuously pumping Ca 2ϩ from the cytoplasm back into the ER, we propose that ATP depletion is not causative of abnormal phenotype. The ratio of AlamarBlue fluorescence, a robust indicator of cellular metabolism to actual cell number was similar in all cells at all time points directly indicating that the expression of hRyR2 (Fig. 7B, panel a) or following its modulation of hRyR2 using ryanodine (Fig. 7B, panel b) or co-expression of FKBP12 or FKBP12.6 (Fig. 7B, panels c and d, respectively) did not compromise the metabolic activities of CHO H and CHO L cells, which were indistinguishable from those of CHO WT (Fig. 7B,  panels a-d) . Second, expression-profiling analysis of CHO H demonstrated that increased Ca 2ϩ flux mediates precise Ca 2ϩ -dependent (ryanodine-sensitive) transcriptional alterations in intracellular signaling networks (55) . In view of our data, we propose that increased Ca 2ϩ flux results in the specific modulation of signaling pathways, which are directly causative of the CHO hRyR2 phenotype. The finding that the expression levels of hRyR2 determined the extent of intracellular Ca 2ϩ dysregulation and the degree of phenotypic modulation is an important conclusion of the present work. The CHO hRyR2 cell model represents a powerful platform to study the role of RyR2 on cellular function in an FKBP12.6-deficient context. Furthermore, our demonstration that reconstitution of the RyR2⅐FKBP12.6 complex in intact cells inhibited aberrant ER-cytoplasmic Ca 2ϩ flux and resulted in complete restoration of normal cellular phenotype represents a significant advance in the characterization of RyRmediated signaling in cell function. It would be interesting to determine whether similar phenotypes are established as a consequence of defective functionality of other Ca 2ϩ regulatory molecules or whether those elucidated in this study represent RyR-specific alterations in cellular phenotype. However, in the present context, our data suggest that increased Ca 2ϩ flux in resting CHO hRyR2 precisely modulates signaling programs involved in cell viability and proliferation, and our cell model could enable the determination of the impact of defective RyRdriven Ca 2ϩ signaling on other diverse cellular processes.
